Hyprevention Raises New Financing to Commercialize Spinal Implant Product V-STRUT© in the USA

Hyprevention CEO Cecile Vienney notes, “We are delighted that our existing investors have shown confidence in our product development efforts and commercialization plans for the US market by increasing their investment in the company."

Continue ReadingHyprevention Raises New Financing to Commercialize Spinal Implant Product V-STRUT© in the USA